Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Valmet expands IQ Quality Control System for sustainable packaging and nonwoven industries

Valmet Oyj trade press release, November 12, 2024, at 9:30 a.m. EETValmet has expanded its IQ Quality Control System (QCS) offering by launching four new IQ Measurements for accurately measuring raw material components, color, and ash content. The new measurements allow packaging and nonwoven producers to maintain the desired product quality while further optimizing raw material usage, resulting in increased resource efficiency and reduced carbon footprint. “Valmet IQ is a leading brand in the industry, and this launch demonstrates our ongoing commitment to developing automation

Himalaya Shipping Ltd. (HSHP) - Mandatory Notification of Trade by PDMR

Hamilton, Bermuda, November 12, 2024: On November 11, 2024, Mr. Bjorn Isaksen entered into a forward purchase agreement with Drew Holdings Ltd. to purchase 200,000 common shares in Himalaya Shipping Ltd. for settlement on June 15, 2026 at a price of $7.13 per share, to be adjusted by 5% interest less any dividends paid between November 11, 2024 and the settlement date. Mr. Isaksen is the chairman of Himalaya Shipping Ltd.'s board and thus, as per the Market Abuse Directive, a person discharging managerial responsibilities in Himalaya Shipping Ltd. Mr. Isaksen and his close associates

Crunchfish receives additional subscriptions in the ongoing rights issue

Larger owners of unit rights in the ongoing rights issue of units in Crunchfish AB (“Crunchfish” or the “Company”), with subscription period from and including November 6, 2024, to and including November 20, 2024 (the “Rights Issue”), have announced their intention to subscribe for shares in the Rights Issue for an additional amount of SEK 1.1 million. Among others, Mats Kullenberg, who previously has submitted subscription commitments of SEK 0.5 million, has announced his intention to subscribe for an additional amount of SEK 0.4 million, fully subscribing for his pro rata share of the

Interim report, July - September 2024

For Q3 2024 net sales increased by 24% compared to Q3 2023. Consolidated net sales ended at 100,469 (SEK 000s). EBITDA totaled to 17,759 (SEK 000s). Operating profit, EBIT, was -3,417 (SEK 000s). Profit after tax was -13,949 (SEK 000s). Earnings per share was SEK -0.21.CEO’s comments Continued strong momentum with exciting growth areas ahead; agreement with KKR on sale of ERP subsidiaries and assets I am truly excited about today's news regarding 24SevenOffice Group AB has entered into an agreement with KKR—one of the world's largest and most esteemed investment firms—to acquire

Tietoevry Care and Helsinki University Hospital strengthen partnership in health data platform development

Leading European health data solutions being developed in Finland. Helsinki University Hospital (HUS) – the largest specialized healthcare provider in Finland - and Tietoevry Care – a leading provider of health and social care software - have agreed on a partnership to develop data and AI solutions. This strategic partnership started in 2016, and the value of the newly signed deal is 24 million euros.Agile data and AI development accelerates medical research in the HUS region in Finland and enables HUS to improve its operational efficiency as a leading health care service provider.

AstraZeneca invests $3.5 billion in US

12 November 2024 AstraZeneca invests $3.5 billionin R&D and manufacturing in the United States AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company's research and manufacturing footprint by the end of 2026. This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs contributing to the growth of the US economy. AstraZeneca's expanding footprint in the US includes, among others: ·       A state-of-the-art R&D centre in Kendall Square, Cambridge, Massachusetts ·       A next

24SevenOffice Group AB and KKR Enter into Agreement on Sale of Certain Subsidiaries and Assets

Reference is made to the press release issued by 24SevenOffice Group AB (the “Group Listed Company” or “24SevenOffice”) on 11 October 2024 announcing that the Group Listed Company had entered into a Memorandum of Understanding regarding a potential sale of parts of its assets and subsidiaries. 24SevenOffice, a leader in cloud-based enterprise software across the Nordics, is today announcing that the Group Listed Company has entered into a definitive agreement with Abacus Bidco Oy (the “Purchaser”), the holding company of Accountor Software, which is majority owned by funds managed by KKR, a

Japanese concept restaurant for Kungstorget by summer 2025

By summer 2025, the duo behind the popular Evolushi in Gothenburg are planning a new concept restaurant in Wallenstam’s premises at Kungstorget 2. Japanese tradition will meet contemporary elegance with dishes such as fusion ramen, gyoza, yakitori and wonderful cocktails. It will be a new meeting place for food, drinks and a fantastic atmosphere right in the heart of Gothenburg, a holistic experience for all the senses.“This is an inspiring new challenge for us and we are looking forward to the opening so much. We love Japanese cuisine and we want the guests to see, smell, hear and

KOMET Phase III trial met primary endpoint

12 November 2024 Koselugo showed statistically significant and clinically meaningful objective response rate vs. placebo in adults with neurofibromatosis type 1 in global KOMET Phase III trial Results demonstrated reduction in tumour volume, building on established safety and efficacy profile of Koselugo in children and supporting expanded use in adults Positive high-level results of KOMET, the largest, global randomised double-blind placebo-controlled multicentre Phase III trial in adults with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (

Cortopia Studios Announces Development of Upcoming VR Title with Free Lives and Devolver Digital

Cortopia Studios, a leader in virtual reality game development, today announced a partnership with Free Lives, the studio behind popular titles such as Broforce and Anger Foot, and publisher Devolver Digital, to develop a previously disclosed but unnamed VR game. “We’re pleased to work with Free Lives and Devolver Digital on this project,” said Ace St. Germain, CEO of Beyond Frames Entertainment, Cortopia Studios’ parent company. “This collaboration will ensure we’re super-serving our player base.” Further details will be released as development progresses.

Dato-DXd new BLA submitted, NSQ BLA withdrawn

12 November 2024 Datopotamab deruxtecan new BLA submitted for accelerated approval in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer AstraZeneca and Daiichi Sankyo's new application is based on the TROPION-Lung05 Phase II trial and supported by data from additional trials including TROPION-Lung01   Previously submitted BLA based on TROPION-Lung01 Phase III trial for patients with nonsquamous NSCLC has been voluntarily withdrawn AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated

Veidekke ASA: To build a new preschool in Tyresö, Sweden

Veidekke has been contracted by Tyresö municipality, near Stockholm, to build a new preschool in Bollmora which will accommodate 160 children. The contract value is approximately SEK 125 million.Central Tyresö requires more permanent preschool capacity under municipal auspices, and the municipality has tasked Veidekke with building a new preschool adjacent to Bergfotens school. “Tyresö is constantlig developing. In building for our community, we aim to promote the Tyresö values and think sustainably, humanely, green and blue. With this in mind, we look forward to starting the

Repurchases of shares during week 45, 2024

Between 4 November and 8 November 2024 Attendo AB (LEI code 549300KEJDL2FNITUW65) (“Attendo”) has repurchased in total 317,285 own shares (ISIN: SE0007666110) as part of the repurchase program initiated by the Board.The repurchases form part of the repurchase program of a maximum of 16,138,659 own shares for a total maximum amount of SEK 150,000,000 that Attendo announced on 24 October 2024. The repurchase program, which runs between 25 October 2024 and 6 February 2025, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated

Moberg Pharma´s Interim report January - September 2024

TERCLARA WINS LAUNCH OF THE YEAR AT KRONANS PHARMACY AND DOZ PHARMACYNINE-MONTH PERIOD (JAN-SEP 2024) · Net revenue SEK 8.8 million (0) · EBITDA SEK -15.7 million (-17.4) · Operating profit (EBIT) SEK -16.7 million (-19.2) · Total profit SEK -11.8 million (-14.6) · Diluted earnings per share SEK -0.34 (-1.24) · Cash and cash equivalents amounted to SEK 309.0 million (101.5) THIRD QUARTER (JUL-SEP 2024) · Net revenue SEK 3.9 million (0) · EBITDA SEK -3.0 million (-6.6) · Operating profit (EBIT) SEK -3.3 million (-7.3) · Total profit SEK -1.3 million (-5.8)

ASSA ABLOY acquires IXLA in Italy

ASSA ABLOY has acquired IXLA, an Italian Manufacturer of advanced laser and color personalization systems for cards and passports. "I am very pleased to welcome the IXLA team into the ASSA ABLOY Group. IXLA is an interesting technological addition to the ASSA ABLOY Group and will increase our presence in the government card personalization equipment space and provides complementary growth opportunities,” says Nico Delvaux, President and CEO of ASSA ABLOY. “Welcoming IXLA into the HID family demonstrates our commitment to providing convenient and efficient document personalization

First Asia Contract Win

12 November 2024   Gaming Innovation Group Software Plc (“GiG” or the “Company”)   First Asia Contract Win   Key milestone achieved as GiG enters Asia via agreement with Filipino land-based casino group   Gaming Innovation Group Software Plc (First North: GiG SDB), a leading B2B iGaming technology provider, is pleased to announce that it has secured a long-term agreement with Bloomberry Resorts Corporation (“Bloomberry”) and its flagship brand Solaire Resorts (“Solaire”), one of the Philippines’ largest and most established land-based casino and leisure groups (

CS MEDICA A/S: Update on the Strategic Rationale Behind CANNORDIC IPO and Aim for Capital Increase

CS MEDICA A/S Announces Key Updates Ahead of the Extraordinary General Meeting (EGM) today: Developments in CANNORDIC’s Capital Increase, IPO Progress, and Share Allocation to CS MEDICA Shareholders, with a Cut-Off Date Set for November 22, 2024.CS MEDICA is now conducting a capital raise in its CANNORDIC, which provides the group with an opportunity to accelerate sales, marketing, and development. The company’s growth has been hindered for some time due to a lack of liquidity to implement key growth initiatives. CS MEDICA’s management, together with external advisors, has determined that

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release 12 November 2024 at 9.00 a.m. (EET) Sitowise Group Plc (the "Company") has on 11 November 2024 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley, according to which Morgan Stanley & Co International Plc's holding of the shares and votes of the Company has increased above 5.00 percent on 8 November 2024. According to the notification, Morgan Stanley holds indirectly a total of 46,448 shares corresponding to 0.13 percent of the Company’s shares and votes, and a total of

There are no items matching the current filter
There are no more items matching the current filter
Back to top